Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Young Biotech is a South Korean biotechnology company specializing in regenerative medicine through the development of stem cell and exosome-based therapeutics. The company focuses on addressing unmet needs in dermatology and orthopedics, with a primary emphasis on hair loss (alopecia), skin regeneration, and osteoarthritis. Its proprietary platform enables the large-scale production of high-purity exosomes derived from human stem cells, which serve as the foundation for its lead candidate, YB-101. In addition to its therapeutic pipeline, Young Biotech commercializes advanced stem cell culture media and bio-active ingredients for the global aesthetic and cosmetic industries. The company is headquartered in Incheon's Songdo Bio Cluster, a major hub for biopharmaceutical innovation in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on young biotech.